Windtree Therapeutics Inc’s recently made public that its President and CEO Fraser Craig acquired Company’s shares for reported $4942.0 on Oct 08 ’24. In the deal valued at $0.91 per share,5,431 shares were bought. As a result of this transaction, Fraser Craig now holds 8,638 shares worth roughly $19435.5.
Ladenburg Thalmann initiated its Windtree Therapeutics Inc [WINT] rating to a Buy in a research note published on June 26, 2020; the price target was $12.25.
Price Performance Review of WINT
On Tuesday, Windtree Therapeutics Inc [NASDAQ:WINT] saw its stock fall -22.68% to $2.25. Over the last five days, the stock has lost -38.86%. Windtree Therapeutics Inc shares have fallen nearly -87.12% since the year began. Nevertheless, the stocks have fallen -99.31% over the past one year. While a 52-week high of $737.43 was reached on 01/02/25, a 52-week low of $2.90 was recorded on 03/04/25. SMA at 50 days reached $9.63, while 200 days put it at $135.85.
Levels Of Support And Resistance For WINT Stock
The 24-hour chart illustrates a support level at 2.00, which if violated will result in even more drops to 1.76. On the upside, there is a resistance level at 2.57. A further resistance level may holdings at 2.90. The Relative Strength Index (RSI) on the 14-day chart is 18.66, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.05%. Stochastics %K at 0.95% indicates the stock is a buying.
